Időskori makuladegeneráció: vizsgálatok itt: Magyarország
12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
- Where
- Budapest VI, Budapest VIII, Budapest XIII, Debrecen, Pécs
- Életkor
- 50 év and over
- People
- 272 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07441642 · EU 2025-523704-77-00 - 3. fázisTaking peopleA Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Where
- Budapest, Budapest VI, Budapest VIII, Budapest XIII, Debrecen, Pécs, Szeged, Szombathely
- Életkor
- 50 év to 85 év
- People
- 975 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06541704 · EU 2023-509547-27-00 - 2/3. fázisTaking peopleA Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Where
- Budapest VI, Pécs, Zalaegerszeg
- Életkor
- 60 év and over
- People
- 274 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06635148 · EU 2022-500747-21-00 - 3. fázisTaking peopleStudy to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
- Where
- Budapest VIII, Budapest XIII, Debrecen, Pécs
- Életkor
- 50 év and over
- People
- 561 worldwide
- Run by
- AbbVie
See details and how to joinNCT07007065 · EU 2024-512298-28-00 - 3. fázisTaking peopleSingle Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Where
- Budapest, Debrecen, Pécs, Szeged
- Életkor
- 50 év and over
- People
- 480 worldwide
- Run by
- 4D Molecular Therapeutics
See details and how to joinNCT07064759 - 3. fázisTaking peopleA Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
- Where
- Budapest, Budapest VI, Budapest VIII, Budapest XIII, Debrecen, Pécs, Szeged, Szombathely, Zalaegerszeg
- Életkor
- 50 év and over
- People
- 304 worldwide
- Run by
- Amgen
See details and how to joinNCT07614776 · EU 2025-523500-72-00 - 2/3. fázisNot yet taking people in MagyarországA Phase II/III Multicenter, Randomized, Masked, Active Comparator-Controlled Study to Evaluate the Safety and Efficacy of Two Doses of OCUL101, an Anti-VEGF and Anti-Complement C5, Bi-specific Humanized Antibody-Like “trap” in Participants with Neovascular Age-Related Macular Degeneration with or without Geographic Atrophy – STAT Study
- Where
- Budapest, Budapest VIII, Debrecen, Pécs, Szeged
- Életkor
- 65 év and over
- People
- 125 worldwide
- Run by
- Shenzhen Oculgen Biomedical Technology Co. Ltd.
See details and how to join2026-526648-11-00 · EU 2026-526648-11-00 - 2/3. fázisTaking peopleA clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003)
- Where
- Budapest, Budapest VI, Budapest VIII, Budapest X, Budapest XIII, Debrecen, Pécs, Szeged, Zalaegerszeg
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- Eyebiotech Limited
See details and how to join2025-524894-17-00 · EU 2025-524894-17-00 - 2. fázisTaking peopleStudy to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Where
- Budapest, Budapest VI, Budapest VIII, Budapest XIII, Debrecen, Pécs, Szeged
- Életkor
- 55 év and over
- People
- 324 worldwide
- Run by
- ONL Therapeutics
See details and how to joinNCT06659445 · EU 2024-513174-22-00 - 2. fázisTaking peoplePhase 2 Study of ADX-038 in Participants With Geographic Atrophy
- Where
- Budapest, Debrecen, Pécs
- Életkor
- 60 év and over
- People
- 240 worldwide
- Run by
- ADARx Pharmaceuticals, Inc.
See details and how to joinNCT06990269 · EU 2025-521779-30-00 - 2/3. fázisTaking peopleA Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- Where
- Budapest
- Életkor
- 50 év and over
- People
- 960 worldwide
- Run by
- EyeBiotech Ltd.
See details and how to joinNCT07496567 - 2. fázisCsak meghívásosLong-term Follow-Up Study of RGX-314 and Fellow Eye Substudy
- Where
- Budapest XIII, Debrecen, Pécs
- Életkor
- 50 év and over
- People
- 865 worldwide
- Run by
- AbbVie
See details and how to joinNCT03999801 · EU 2023-505750-17-00